February 2020 has seen a flurry of regulatory activity in India, with the ministry of health and family welfare setting out norms that expand responsibility for the quality of drugs and compliance issues beyond manufacturers.
Changes have also been proposed to the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, with new prison terms and fines awaiting those who violate the provisions
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?